JHS Svendgaard Laboratories Limited (IN:JHS)
:JHS
Want to see IN:JHS full AI Analyst Report?
JHS Stock Chart & Stats
₹9.34
₹0.02(0.10%)
At close: 4:00 PM EST
₹9.34
₹0.02(0.10%)
Day’s Range― - ―
52-Week Range₹6.15 - ₹14.04
Previous CloseN/A
Volume57.31K
Average Volume (3M)16.78K
Market Cap
₹674.56M
Enterprise Value₹746.79M
Total Cash (Recent Filing)₹200.11M
Total Debt (Recent Filing)₹105.87M
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Aug 17, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.95
Shares Outstanding85,603,966
10 Day Avg. Volume16,348
30 Day Avg. Volume16,781
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)0.33
Price to Sales (P/S)0.56
P/FCF Ratio-3.84
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Balance Sheet StrengthLow leverage and a stable asset/equity base give the company durable solvency flexibility, reducing default and refinancing risk. Over 2–6 months this balance-sheet strength supports continued operations, potential opportunistic investment, and resilience against cyclical revenue swings.
Contract Manufacturing / Diversified Revenue StreamsA dual model of branded sales plus contract manufacturing provides structural revenue diversification and asset utilization. Durable third-party manufacturing contracts can smooth demand variability, deliver steady throughput and margins tied to volumes, and reduce reliance on single-channel retail trends.
Revenue Recovery And EBITDA TurnaroundAn 8.7% revenue recovery with EBITDA back in positive territory suggests operational leverage and improving core cash profits. If sustained, this trend supports reinvestment, reduces need for external funding, and indicates the business can regain profitability as volumes recover or cost actions persist.
Bears Say
Ongoing Net LossesPersistent operating losses erode retained earnings and limit internal funding for growth or product investment. Over months, continued negative margins constrain strategic flexibility, elevate dependence on cash reserves or financing, and make it harder to convert balance-sheet strength into shareholder returns.
Weak Cash Generation / Cash BurnRecurrent negative operating and free cash flow increases execution risk and the potential need for external financing. In a 2–6 month view, weak cash generation can force cost cuts, delay capex or R&D, and limit the ability to capitalize on market recovery or expand contract-manufacturing capacity.
Compressed Gross Margins / Pricing PressureMaterial margin compression signals structural pressure on unit economics from input costs or competitive pricing. Over the medium term this reduces profit per sale, narrows the gap to breakeven, and limits capacity to absorb rising SG&A or invest in brand building without improving pricing or cost base.
JHS Svendgaard Laboratories Limited News
JHS FAQ
What was JHS Svendgaard Laboratories Limited’s price range in the past 12 months?
JHS Svendgaard Laboratories Limited lowest stock price was ₹6.15 and its highest was ₹14.04 in the past 12 months.
What is JHS Svendgaard Laboratories Limited’s market cap?
JHS Svendgaard Laboratories Limited’s market cap is ₹674.56M.
When is JHS Svendgaard Laboratories Limited’s upcoming earnings report date?
JHS Svendgaard Laboratories Limited’s upcoming earnings report date is Aug 17, 2026 which is in 69 days.
How were JHS Svendgaard Laboratories Limited’s earnings last quarter?
JHS Svendgaard Laboratories Limited released its earnings results on May 26, 2026. The company reported -₹0.42 earnings per share for the quarter, missing the consensus estimate of N/A by -₹0.42.
Is JHS Svendgaard Laboratories Limited overvalued?
According to Wall Street analysts JHS Svendgaard Laboratories Limited’s price is currently Overvalued.
Does JHS Svendgaard Laboratories Limited pay dividends?
JHS Svendgaard Laboratories Limited pays a Annually dividend of ₹0.75 which represents an annual dividend yield of N/A. See more information on JHS Svendgaard Laboratories Limited dividends here
What is JHS Svendgaard Laboratories Limited’s EPS estimate?
JHS Svendgaard Laboratories Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JHS Svendgaard Laboratories Limited have?
JHS Svendgaard Laboratories Limited has 85,603,966 shares outstanding.
What happened to JHS Svendgaard Laboratories Limited’s price movement after its last earnings report?
JHS Svendgaard Laboratories Limited reported an EPS of -₹0.42 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5%.
Which hedge fund is a major shareholder of JHS Svendgaard Laboratories Limited?
Currently, no hedge funds are holding shares in IN:JHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JHS Svendgaard Laboratories Limited
JHS Svendgaard Laboratories Limited, along with its associated companies, specializes in the manufacturing and sale of a diverse array of oral and dental hygiene products, catering to both adults and children throughout India. Their extensive product range includes essential oral care items such as toothbrushes, toothpastes, and mouthwashes, predominantly marketed under the Dr. Gold and Aquawhite brand names. The company also produces other personal and household goods, including hand sanitizers, laundry detergents, room fresheners, and denture care solutions. Beyond its own brands, JHS Svendgaard Laboratories provides contract manufacturing services for oral care products to other companies and operates retail outlets within various airports. The firm also engages in international trade, exporting its goods to global markets. Established in 1996, the company's base of operations is situated in New Delhi, India.
Technical Analysis
Colgate-Palmolive (India) Limited
―
Dabur India Limited
―
Emami Limited
―
Godrej Consumer Products Limited
―
Honasa Consumer Limited
―